vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and COFFEE HOLDING CO INC (JVA). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $27.7M, roughly 1.6× COFFEE HOLDING CO INC). COFFEE HOLDING CO INC runs the higher net margin — 2.9% vs -23.3%, a 26.2% gap on every dollar of revenue. On growth, COFFEE HOLDING CO INC posted the faster year-over-year revenue change (30.8% vs 7.0%). Over the past eight quarters, COFFEE HOLDING CO INC's revenue compounded faster (19.2% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Black Rifle Coffee Company (BRCC) is a coffee company based in Salt Lake City, Utah, United States. Founded in 2014 by former U.S. Army Green Beret Evan Hafer, it gained national attention in 2017 after pledging to hire 10,000 veterans in response to Starbucks's pledge to hire 10,000 refugees.

AMRN vs JVA — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.6× larger
AMRN
$45.1M
$27.7M
JVA
Growing faster (revenue YoY)
JVA
JVA
+23.8% gap
JVA
30.8%
7.0%
AMRN
Higher net margin
JVA
JVA
26.2% more per $
JVA
2.9%
-23.3%
AMRN
Faster 2-yr revenue CAGR
JVA
JVA
Annualised
JVA
19.2%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
JVA
JVA
Revenue
$45.1M
$27.7M
Net Profit
$-10.5M
$811.5K
Gross Margin
8.5%
Operating Margin
35.5%
2.8%
Net Margin
-23.3%
2.9%
Revenue YoY
7.0%
30.8%
Net Profit YoY
33.0%
-35.7%
EPS (diluted)
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
JVA
JVA
Q1 26
$45.1M
Q4 25
$49.2M
$27.7M
Q3 25
$49.7M
$23.9M
Q2 25
$72.7M
$23.3M
Q1 25
$42.0M
$21.3M
Q4 24
$62.3M
$21.2M
Q3 24
$42.3M
$18.8M
Q2 24
$67.5M
$19.0M
Net Profit
AMRN
AMRN
JVA
JVA
Q1 26
$-10.5M
Q4 25
$-1.2M
$811.5K
Q3 25
$-7.7M
$-1.2M
Q2 25
$-14.1M
$644.1K
Q1 25
$-15.7M
$1.2M
Q4 24
$-48.6M
$1.3M
Q3 24
$-25.1M
$626.8K
Q2 24
$1.5M
$-21.8K
Gross Margin
AMRN
AMRN
JVA
JVA
Q1 26
Q4 25
47.1%
8.5%
Q3 25
44.7%
12.2%
Q2 25
69.2%
18.9%
Q1 25
59.8%
26.9%
Q4 24
-15.4%
23.2%
Q3 24
38.5%
20.9%
Q2 24
63.4%
19.5%
Operating Margin
AMRN
AMRN
JVA
JVA
Q1 26
35.5%
Q4 25
-12.9%
2.8%
Q3 25
-22.4%
-4.6%
Q2 25
-22.0%
3.8%
Q1 25
-39.9%
7.5%
Q4 24
-84.3%
8.0%
Q3 24
-59.5%
3.8%
Q2 24
-0.8%
-0.4%
Net Margin
AMRN
AMRN
JVA
JVA
Q1 26
-23.3%
Q4 25
-2.5%
2.9%
Q3 25
-15.6%
-5.0%
Q2 25
-19.4%
2.8%
Q1 25
-37.4%
5.4%
Q4 24
-78.0%
5.9%
Q3 24
-59.4%
3.3%
Q2 24
2.3%
-0.1%
EPS (diluted)
AMRN
AMRN
JVA
JVA
Q1 26
Q4 25
$0.00
$0.15
Q3 25
$-0.02
$-0.21
Q2 25
$-0.03
$0.11
Q1 25
$-0.04
$0.20
Q4 24
$-0.12
$0.22
Q3 24
$-0.06
$0.11
Q2 24
$0.00
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
JVA
JVA
Cash + ST InvestmentsLiquidity on hand
$307.8M
$701.9K
Total DebtLower is stronger
Stockholders' EquityBook value
$27.6M
Total Assets
$645.8M
$42.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
JVA
JVA
Q1 26
$307.8M
Q4 25
$302.6M
$701.9K
Q3 25
$286.6M
$979.8K
Q2 25
$298.7M
$1.8M
Q1 25
$281.8M
$2.4M
Q4 24
$294.2M
$1.4M
Q3 24
$305.7M
$3.1M
Q2 24
$306.7M
$2.4M
Stockholders' Equity
AMRN
AMRN
JVA
JVA
Q1 26
Q4 25
$459.3M
$27.6M
Q3 25
$458.9M
$26.8M
Q2 25
$464.9M
$28.0M
Q1 25
$473.7M
$27.3M
Q4 24
$486.2M
$26.2M
Q3 24
$531.4M
$24.9M
Q2 24
$551.9M
$24.3M
Total Assets
AMRN
AMRN
JVA
JVA
Q1 26
$645.8M
Q4 25
$670.8M
$42.0M
Q3 25
$659.8M
$45.9M
Q2 25
$670.1M
$39.7M
Q1 25
$655.7M
$38.9M
Q4 24
$685.3M
$34.0M
Q3 24
$750.6M
$33.1M
Q2 24
$799.9M
$34.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
JVA
JVA
Operating Cash FlowLast quarter
$377.7K
Free Cash FlowOCF − Capex
$265.4K
FCF MarginFCF / Revenue
1.0%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
0.47×
TTM Free Cash FlowTrailing 4 quarters
$-5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
JVA
JVA
Q1 26
Q4 25
$15.3M
$377.7K
Q3 25
$-12.7M
$-3.8M
Q2 25
$16.6M
$-1.2M
Q1 25
$-12.5M
$-401.9K
Q4 24
$-13.3M
$222.0K
Q3 24
$-2.4M
$1.8M
Q2 24
$-2.7M
$-1.2M
Free Cash Flow
AMRN
AMRN
JVA
JVA
Q1 26
Q4 25
$265.4K
Q3 25
$-3.9M
Q2 25
$-1.2M
Q1 25
$-419.8K
Q4 24
Q3 24
$1.8M
Q2 24
FCF Margin
AMRN
AMRN
JVA
JVA
Q1 26
Q4 25
1.0%
Q3 25
-16.3%
Q2 25
-5.0%
Q1 25
-2.0%
Q4 24
Q3 24
9.4%
Q2 24
Capex Intensity
AMRN
AMRN
JVA
JVA
Q1 26
Q4 25
0.4%
Q3 25
0.2%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
Q3 24
0.2%
Q2 24
Cash Conversion
AMRN
AMRN
JVA
JVA
Q1 26
Q4 25
0.47×
Q3 25
Q2 25
-1.79×
Q1 25
-0.35×
Q4 24
0.18×
Q3 24
2.90×
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

JVA
JVA

Segment breakdown not available.

Related Comparisons